Chemotactic assays in vitro suggested that high level of CCL1 and CCL18 in the TME of ovarian cancer contributed to the increased infiltration of CD4+CCR8+ Tregs into tumor tissues. This evidence concerns the gene CCL1 and ovarian carcinoma.